LifeMine Closes Watertown's Largest Funding Round of 2026 and EyePoint's Phase 3 Miss
Plus a flurry of clinical trial updates and quarterly reports
Plus Werewolf Finds a Buyer
Plus a flurry of clinical trial updates and quarterly reports